Australia vs United States of America: Proportion of isolates with decreased susceptibility or resistance
Australia
0.0666
in 2018
United States of America
0.2907
in 2018
Australia rank
24th
United States of America rank
23rd
Proportion of isolates with decreased susceptibility or resistance over time
- Australia
- United States of America
How they compare
United States of America currently reports 0.2907 against 0.0666 in Australia, a difference of 0.2241.
That makes United States of America's figure about 4.4 times Australia's.
The two have swapped places 4 times across 10 shared years of data; in 2009 it was United States of America ahead.
Australia ranks 24th and United States of America ranks 23rd of 51 countries.
United States of America has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Australia | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0317 | 0.7993 | 0.7676 | United States of America |
| 2010s | 0.4001 | 0.4084 | 0.0083 | United States of America |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Australia or United States of America?
- United States of America, at 0.2907 against 0.0666 in Australia as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Australia and United States of America?
- 0.2241, with United States of America ahead.
- How many years of comparable data are there for Australia and United States of America?
- 10 years are reported by both, from 2009 to 2018.
- How do Australia and United States of America rank globally for proportion of isolates with decreased susceptibility or resistance?
- Australia ranks 24th and United States of America ranks 23rd of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.